PREVORA Dental solution Ref.[50410] Active ingredients: Chlorhexidine

Source: Health Products Regulatory Authority (IE)  Revision Year: 2021  Publisher: CHX Technologies Europe Limited, Guiness Enterprise Centre, Taylors Lane, Dublin 8, Ireland

Product name and form

Prevora 100 mg/ml Dental Solution.

Pharmaceutical Form

Dental Solution.

Stage 1 chlorhexidine coating: A clear, slightly brownish solution with a characteristic odour, free of visible particulate matter.

Stage 2 sealant coating: A milky-white liquid of low viscosity with a faint characteristic odour, free of visible particulate matter.

Qualitative and quantitative composition

Each 1 ml of Prevora Dental Solution (Stage 1 chlorhexidine coating) contains chlorhexidine diacetate 100 mg.

Excipients with known effect:

Ethanol 700 mg/ml
Benzoic acid 82 mg/ml

For the full list of excipients, see section 6.1.

Active Ingredient Description
Chlorhexidine

Chlorhexidine is an antimicrobial agent, active against a broad spectrum of Gram-positive and Gram-negative organisms, yeasts, fungi, opportunistic anaerobes and aerobes. Chlorhexidine is mainly a “membrane-acting” agent that destroys the outer membrane of the bacteria. It is inactive on bacterial spores unless the temperatures are high.

List of Excipients

Stage 1 chlorhexidine coating:

Sumatra benzoin (benzoic acid)
Ethanol

Stage 2 sealant coating:

Ammonio methacrylate copolymer dispersion, Type B
Triethyl citrate

Pack sizes and marketing

Prevora 100 mg/ml Dental Solution contains:

Stage 1 chlorhexidine coating:

Chlorhexidine diacetate
Sumatra benzoin (benzoic acid)
Ethanol

Stage 2 sealant coating:

Ammonio methacrylate copolymer dispersion, Type B
Triethyl citrate

One treatment box of Prevora Dental solution contains 6 Type 1 glass vials of Stage 1 chlorhexidine coating along with 6 Type 1 glass vials of Stage 2 sealant coating.

Each vial contains 1 ml of Stage 1 chlorhexidine coating or Stage 2 sealant coating.

Marketing authorization holder

CHX Technologies Europe Limited, Guiness Enterprise Centre, Taylor’s Lane, Dublin 8, Ireland

Marketing authorization dates and numbers

PA1205/001/001

Date of First Authorisation: 5th May 2006
Date of last renewal: 4th May 2011

Drugs

Drug Countries
PREVORA Canada, Ireland

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.